In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vascular Architects completes $16mm Series D round

Executive Summary

Vascular Architects (devices to treat vascular disease and nonvascular obstructions) raised $16mm in a Series D private placement of preferred shares to lead investor Foundation Medical Partners. New investor Edwards Lifesciences was joined by returning investors Domain Associates, Arch Venture Partners, Johnson & Johnson Development Corp., Vertical Group, Atherton Venture Partners, Three Arch Partners, and company founder Thomas Fogarty, MD.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies